SEC Form 4 · accession 0001209191-18-051419
AERIE PHARMACEUTICALS INC · AERI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard J Rubino
Officer — Chief Financial Officer
Period of report
Sep 14, 2018
Accepted (ET)
Sep 18, 2018 · 4:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001337553
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 14, 2018 | S | 2 | $60.00 | D | 383,736 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares, along with the 34,512 shares sold by the reporting person on September 13, 2018 (as reported on the Form 4 filed on September 14, 2018), were sold pursuant to the reporting person's Rule 10b5-1 plan.